Hypoglycemia in a healthy patient without diabetes is uncommon and warrants further evaluation. Although patients without diabetes may routinely have blood glucose concentrations in the 60 mg/dL (3.3 mmol/L) range, most healthy patients without chronic hypoglycemia develop symptoms of hypoglycemia with a plasma glucose concentration below 55 mg/dL (3.0 mmol/L) (1). The plasma glucose of 28 mg/dL (1.6 mmol/L) in this case in combination with altered mental status warranted immediate medical attention.

Many of the laboratory tests used to evaluate hypoglycemia must be performed while the blood glucose is low, whether due to spontaneous hypoglycemia or during a supervised fast. Increased or inappropriately normal insulin and C-peptide concentrations during hypoglycemia can result from endogenous hyperinsulinism or a medication that stimulates pancreatic insulin release, such as a sulfonylurea. A sulfonylurea screen is also ideally performed close to the time of hypoglycemia when blood concentrations of the medication are likely to be high but can provide useful information even if drawn after treating hypoglycemia.

Medication-induced hypoglycemia is often accidental, although it may be surreptitious or malicious. Even in patients without known access to diabetes medications, careful identification of all medications, including prescriptions and over-the-counter products, is crucial. This case illustrates a public health success with over-the-counter products. Healthcare providers obtained history from the patient of use of the male enhancement supplement marketed as “V8” and suspected exposure to a hypoglycemic agent based on symptoms. Because similar cases had been reported to poison centers, the Virginia Department of Health and Virginia Department of Agriculture and Consumer Services were able to issue warnings to consumers and health professionals within days of the first reported cases and eventually removed the product from shelves across Virginia (2). Notifications were sent to other states to prevent the public from greater harm.

Author Contributions

All authors confirmed they have contributed to the intellectual content of this paper and have met the following 4 requirements: (a) significant contributions to the conception and design, acquisition of data, or analysis and interpretation of data; (b) drafting or revising the article for intellectual content; (c) final approval of the published article; and (d) agreement to be accountable for all aspects of the article thus ensuring that questions related to the accuracy or integrity of any part of the article are appropriately investigated and resolved.

Authors' Disclosures or Potential Conflicts of Interest

No authors declared any potential conflicts of interest.

References

1

Cryer
PE
,
Axelrod
L
,
Grossman
AB
,
Heller
SR
,
Montori
VM
,
Seaquist
ER
,
Service
FJ
; Endocrine Society.
Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline
.
J Clin Endocrinol Metab
2009
;
94
:
709
28
.

2

Ross
JA
,
Downs
JW
,
Bazydlo
LA
,
Bordwine
PH
,
Gineste
CE
,
Kopatic
MC
, et al.
Outbreak of severe hypoglycemia after ingestion of a male enhancement supplement—Virginia, August–November 2019
.
MMWR Morb Mortal Wkly Rep
2020
;
69
:
740
3
.

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://dbpia.nl.go.kr/journals/pages/open_access/funder_policies/chorus/standard_publication_model)